A multicenter, real‐world analysis of primary central nervous system lymphoma in those with and without human immunodeficiency virus-Reference-Cited by-同舟云学术

A multicenter, real‐world analysis of primary central nervous system lymphoma in those with and without human immunodeficiency virus

Published:2022-06-02 Issue:3 Volume:3 Page:734-738
ISSN:2688-6146
Container-title:eJHaem
language:en
Short-container-title:eJHaem

Author:

Dittus Christopher¹^ORCID,Grover Natalie¹,Sethi Tarsheen²,Cohen Jonathon B.³,Voloschin Alfredo³,Rabadey Janhvi¹,Tan Xianming¹⁴,Beaven Anne¹,Park Steven I.⁵

Affiliation:

1. Division of Hematology University of North Carolina at Chapel Hill Chapel Hill North Carolina USA

2. Division of Hematology Yale University New Haven Connecticut USA

3. Department of Hematology and Medical Oncology Emory University‐Winship Cancer Institute Atlanta Georgia USA

4. Department of Biostatistics University of North Carolina at Chapel Hill Chapel Hill North Carolina USA

5. Atrium Health Levine Cancer Institute Charlotte North Carolina USA

Publisher

Wiley

Subject

General Earth and Planetary Sciences

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/jha2.474

Reference10 articles.

1. Primary CNS Lymphoma

2. 2016 US lymphoid malignancy statistics by World Health Organization subtypes

3. Primary CNS lymphoma in HIV positive and negative patients: comparison of clinical characteristics, outcome and prognostic factors

4. Rituximab, Methotrexate, Procarbazine, and Vincristine Followed by Consolidation Reduced-Dose Whole-Brain Radiotherapy and Cytarabine in Newly Diagnosed Primary CNS Lymphoma: Final Results and Long-Term Outcome

5. R-MPV followed by high-dose chemotherapy with TBC and autologous stem-cell transplant for newly diagnosed primary CNS lymphoma

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Sustained response following BTK inhibitors based treatment in HIV-related primary central nervous system lymphoma: case report;AIDS Research and Therapy;2023-08-29

2. Use of programmed cell death protein 1 (PD-1) inhibitor therapy in HIV-infected patients with advanced cancer: a single-center study from China;Infectious Agents and Cancer;2023-05-30

3. Use of Programmed Cell Death Protein 1 (PD-1) Inhibitor Therapy in HIV-infected Patients with Advanced Cancer:a single-center study from China;2023-01-24